Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

A Laboratory’s Perspective: How the University of Louisville Infectious Diseases Lab Leverages Molecular Testing

The University of Louisville Infectious Diseases Laboratory (U of L ID Lab) is a university-based, CLIA-certified, high-complexity reference laboratory, offering testing services related to the diagnosis of infectious diseases.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

RT @StuartHicks13: E. Coli Outbreaks at Hospitals Could be Reduced by Copper-Coated Uniforms | SelectScience
h J R
How can our technology help empower labs to obtain reliable, timely, and actionable answers? The @uofl Infectious D…
h J R
RT @WHO: Here is the recommended composition of #influenza vaccines for use in the 2018-2019 northern hemisphere influenza season https://t
h J R

Latest News

February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

January 24
Luminex Corporation Declares First Quarter Cash Dividend

January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017

December 13
Luminex Corporation Declares Fourth Quarter Cash Dividend

November 14
Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference


Middle Tennessee Antimicrobial Stewardship Symposium
January 26
Memphis, TN

First Coast ID/CM Symposium
February 2-3
Palm Coast, FL

ASM Biothreats
February 12-43
Baltimore, MD

Northern California Branch of the American Society for Microbiology (NCASM) Spring Meeting
March 2-3
Pleasonton, CA

FAH Public Policy Conference & Business Expo
March 4-6
Washington D.C.